National Institutes of Health psilocybin research speaker series: State of the science, regulatory and policy landscape, research gaps, and opportunities.
Saved in:
| Title: | National Institutes of Health psilocybin research speaker series: State of the science, regulatory and policy landscape, research gaps, and opportunities. |
|---|---|
| Authors: | Xi D; National Institutes of Health (NIH), National Cancer Institute (NCI), Division of Cancer Treatment and Diagnosis (DCTD), Office of Cancer Complementary and Alternative Medicine (OCCAM), Rockville, MD, USA. Electronic address: xida@mail.nih.gov., Berger A; NIH Clinical Research Center, Pain and Palliative Care, Bethesda, MD, USA. Electronic address: aberger@cc.nih.gov., Shurtleff D; NIH, National Center for Complementary and Integrative Health (NCCIH), Bethesda, MD, USA. Electronic address: david.shurtleff@nih.gov., Zia FZ; National Institutes of Health (NIH), National Cancer Institute (NCI), Division of Cancer Treatment and Diagnosis (DCTD), Office of Cancer Complementary and Alternative Medicine (OCCAM), Rockville, MD, USA. Electronic address: ziaf@mail.nih.gov., Belouin S; NIH Clinical Research Center, Pain and Palliative Care, Bethesda, MD, USA; United States Public Health Service (USPHS), Germantown, MD, USA; Substance Abuse and Mental Health Services Administration (SAMHSA), Rockville, MD, USA. Electronic address: sean.belouin@samhsa.hhs.gov. |
| Source: | Neuropharmacology [Neuropharmacology] 2023 Jun 01; Vol. 230, pp. 109467. Date of Electronic Publication: 2023 Feb 27. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7064 (Electronic) Linking ISSN: 00283908 NLM ISO Abbreviation: Neuropharmacology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
